The global peripheral vascular devices market, valued at USD 4.7 billion in 2022, is projected to expand at a robust CAGR of 6.6%, reaching USD 8.9 billion by 2032, according to Future Market Insights ...

A new Intermountain Health study finds that peripheral artery disease, a condition that affects more than 10 million Americans over the age of 40, is often underdiagnosed and undertreated ...

The following is a summary of "Impact of Peripheral Arterial Disease on Clinical Outcomes of Patients Undergoing Complex vs ...

April is National Minority Health Month, a time dedicated to acknowledging health disparities that affect minority communities and promoting access to quality health care and disease prevention.

Limus-based devices, rather than being a substitute for paclitaxel as they were once seen, are coming of age in peripheral ...

UK: A Mendelian randomization study published in the Journal of the American College of Cardiology identified elevated ...

CHICAGO — Semaglutide, a glucagon-like peptide (GLP-1) receptor agonist, has shown convincing benefits in yet another population: patients with peripheral arterial disease (PAD). In the STRIDE ...

A new Intermountain Health study finds that peripheral artery disease, a condition that affects more than 10 million Americans over the age of 40, is often underdiagnosed and undertreated ...

The dangers of clogged arteries extend well beyond the workings of your heart. Peripheral artery disease makes it difficult for you to walk, causes non-healing sores in your legs or feet, and creates ...